New data suggests treatment with Wegovy offers ‘remarkable’ cardioprotective effects – before significant weight loss occurs. This week, Danish pharma giant Novo Nordisk announced new data highlighting the early cardiovascular benefits of Wegovy at the European Congress of Obesity. The…
Browsing: All news
Category Added in a WPeMatico Campaign
As the clinical phase begins, Peter Diamandis ou
Petro Trush on turning wartime biotech into peac
New report reveals $8.
Non-profit pours grant funding into research foc
Startup lands $65m and targets clinical trials o
Global competition enters clinical phase as sele
Drug based on naturally occurring protective ant
Foresight model aims to predict disease risk for
2060 Foundation President Gabriel Cian on buildi